Mexico issues first authorizations for cannabis products
The Secretary of Health, through the Federal Commission for the Protection of Sanitary Risks (“COFEPRIS”) announced yesterday the authorization for the first 38 products with cannabis and its derivates, with no THC or psycho-active effects, to enter the Mexican market within the next five weeks.
As mentioned on our previous update, on October 30, 2018, COFEPRIS issued the Guidelines for the Sanitary Control of Cannabis and its Derivatives (Lineamientos en Materia de Control Sanitario de la Cannabis y Derivados de la Misma ). Such guidelines set forth the agency’s criteria to be used in the evaluation and resolution of the applications filed to authorize medical and scientific use of cannabis and its pharmacological derivatives, as well as the commercialization, exportation and importation of cannabis products with 1% or less THC content for industrial use. Since that date, COFEPRIS received 51 applications, out of which 38 fully met the requirements.